CSIMarket Company Name, Ticker, Competitors, else..
 
Avanos Medical Inc   (AVNS)
Other Ticker:  
 
 
Price: $24.0000 $0.46 1.954%
Day's High: $24.06 Week Perf: 0.38 %
Day's Low: $ 23.53 30 Day Perf: 6.52 %
Volume (M): 153 52 Wk High: $ 24.77
Volume (M$): $ 3,679 52 Wk Avg: $20.44
Open: $23.78 52 Wk Low: $17.24



 Market Capitalization (Millions $) 1,080
 Shares Outstanding (Millions) 45
 Employees 4,100
 Revenues (TTM) (Millions $) 650
 Net Income (TTM) (Millions $) 8
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) 20

Avanos Medical Inc
Avanos Medical Inc is a leading medical products and solutions company that specializes in creating innovative and high-quality medical devices and surgical products for a range of medical applications.
Founded in 2018, Avanos Medical Inc is headquartered in Alpharetta, Georgia, USA.
The company offers a wide range of medical products, from respiratory care and pain management products to surgical solutions, including advanced wound care and surgical gloves.
Some of the key product lines offered by the company include the ON-Q Pain Relief System, which offers targeted pain relief after surgery, and the Active-Care System, which provides advanced wound healing solutions.
The company is committed to improving patient outcomes and delivering value to healthcare providers through groundbreaking innovation, differentiated products, and customer-driven solutions.
Avanos Medical is also recognized for its robust research and development program, which is focused on designing new and effective products for the medical field, such as the COOLIEFn Cooled RF System, a minimally invasive pain relief solution.
The company operates in several countries worldwide and has a workforce of over 4,000 employees dedicated to delivering the highest level of quality and care.
Avanos Medical's mission is to continue to provide healthcare providers with cutting-edge medical solutions, while improving patient outcomes and performance in healthcare facilities globally.


   Company Address: 5405 Windward Parkway Alpharetta, 30004 GA
   Company Phone Number: 428-2667   Stock Exchange / Ticker: NYSE AVNS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Avanos Medical Inc

Avanos Medical Inc. Struggles with Weak Sales and Declining Earnings in Q1 2024



Avanos Medical Inc. (AVNS) faces a challenging future as the first quarter of 2024 earnings season reveals concerning financial indicators. The company's negative earnings per share (EPS), declining income, and substantial revenue decline indicate a troubled performance. Furthermore, despite a recent surge, AVNS stock has been on a downward trend, emphasizing the unfavorable outlook for the company.
Financial Performance:
During the first quarter of 2024, Avanos Medical Inc. experienced an increased loss of $0.02 per share, up from $0.01 per share a year ago. Moreover, the Income per Share dropped from $0.24 per share in the previous reporting period. These alarming figures suggest a consistent decline in profitability and highlight the company's inability to generate adequate earnings.
Avanos Medical Inc

AVNS Faces Revenue Decline in Fourth Quarter of 2023

Investors in the stock market have been closely watching the fourth quarter of 2023 earnings season, particularly the performance of Avanos Medical Inc. While the company experienced a decline in earnings per share and revenue, there are still some positive signs to be found.
For the period, Avanos Medical Inc's earnings per share dropped by -39.47% to $0.24 per share, compared to $0.39 a year before. However, the company was able to turn a negative earnings per share from the preceding reporting period into a positive one, showing potential for growth in the future.
Although revenue faded by -34.851% to $141.70 million, there is still hope as the on average Medical Equipment & Supplies sector posted a revenue rise of 5.58% from the corresponding reporting period a year ago in the fourth quarter of 2023.
Avanos Medical Inc

Avanos Medical Inc Faces Deficit on Weak Sales in Fiscal Q3 of 2023



Avanos Medical Inc, a leading healthcare company, recently released its financial results for the third quarter of 2023. The figures highlight both positive and negative aspects, raising questions about the company's future trajectory. Let's delve deeper into the implications of these results.
Losses Extend, but EPS Shows Improvement:
Avanos Medical Inc experienced an extension of losses in the fiscal third quarter of 2023, with a negative $0.08 per share compared to $0.33 the previous year. However, there is a silver lining, as the EPS has improved from -$1.46 per share in the prior reporting period. This suggests that the company is actively working towards reducing losses and optimizing profitability.
Avanos Medical Inc

Avanos Medical Inc's Weak Sales in Q2 2023 Lead to Deficit, Raising Concerns Among Investors and Analysts

Avanos Medical Inc, a prominent player in the Medical Equipment & Supplies industry, faced several challenges in the second quarter of 2023. The company recorded a deficit per stock of $-1.46 per share, a significant decline compared to $0.24 per share in the same period last year. This growing deficit from the previous reporting season raises concerns among investors and analysts.
Furthermore, Avanos Medical Inc experienced a substantial decline in revenue, with a decrease of -16.847% to $168.80 million from $203.00 million in the comparable reporting season a year ago. Sequentially, revenue deteriorated by -11.946% from $191.70 million. These declining figures highlight the struggles the company faced in generating sales and retaining market share.






Avanos Medical Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com